Drug toxicology is a branch of pharmacology that focuses on the study of the adverse effects of drugs and other chemical substances on living organisms. It involves assessing the potential harm and toxicity of these substances, including their impact on organs, tissues, and physiological functions. Toxicologists employ various techniques to evaluate the safety of drugs, such as animal testing, cell cultures, and molecular analyses. The goal of drug toxicology is to ensure that medications and substances intended for human use do not cause significant harm or side effects. This field plays a crucial role in drug development, regulatory approval, and post-marketing surveillance. Toxicologists work to identify and understand potential risks associated with therapeutic agents, as well as environmental and occupational exposures. Key aspects of drug toxicology include studying the absorption, distribution, metabolism, and excretion (ADME) of drugs within the body. Toxicologists also examine the mechanisms by which drugs exert their toxic effects, helping to establish safe dosage levels and potential interactions with other substances. With advancements in technology, drug toxicology has evolved to incorporate sophisticated methods like in silico modeling, which uses computer simulations to predict toxicity. This multidisciplinary field continues to contribute significantly to public health by promoting the development of safer and more effective pharmaceuticals.
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami, United States
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : R&D consultancy at the medicines discovery catapult: De-risking drug discovery for innovators
Adriana Gambardella, Medicine Discovery Catapult, United Kingdom
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Biocompatibility and subcutaneous host response to silk fibroin–chitosan composite plugs: Progress toward biodegradable implant materials
Luis Jesus Villarreal Gomez, Universidad Autónoma de Baja California, Mexico